Stay updated with breaking news from Recursion Pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Recursion Pharmaceuticals uses machine learning to develop drugs with Bayer and Genentech. CEO Chris Gibson thinks proceeding with that work outweighs any risks a moratorium might prevent.
/PRNewswire/ -- Ceribell, Inc.®, the pioneer in AI-powered point-of-care neurodiagnostics, today announced Louisa Daniels has joined the medical device company...
The famous growth investor has been making some interesting stock moves lately.
Operator: Good afternoon, and welcome to the Third Quarter Fiscal 2023 Hewlett Packard Enterprise Earnings Conference Call. My name is Gary, and I'll be your conference moderator for today's call.
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) COO Tina Marriott Larson sold 3,000 shares of the company’s stock in a transaction that occurred on Thursday, August 24th. The stock was sold at an average price of $8.66, for a total value of $25,980.00. Following the sale, the chief operating officer now directly owns 418,782 […]